World Rural Health Conference
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 3397
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 8  |  Issue : 3  |  Page : 1227-1231  

An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population


1 Department of Internal Medicine, Interfaith Medical Center, Brooklyn, NY, USA
2 Department of Gastroenterolgy, National Academy of Medical Sciences, Kathmandu, Nepal
3 Department of Gastroenterology, Carilion Clinic, Roanoke, VA, USA

Date of Web Publication27-Mar-2019

Correspondence Address:
Dr. Amrendra Kumar Mandal
Interfaith Medical Center, 1545 Atlantic Ave, Brooklyn, NY - 11213
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jfmpc.jfmpc_82_19

Rights and Permissions
  Abstract 


Background: Helicobacter pylori (H. pylori) is one of the most common human infections worldwide particularly in the developing countries. We aimed to study an association of H. Pylori infection with endoscopic and histological findings in the Nepalese population. Materials and Methods: We conducted a study between Oct 2014 and Jan 2015 after meeting inclusion and exclusion criteria. Institutional Review Board approval was obtained from National Academy of Medical Sciences. Endoscopic findings and histopathological diagnosis were documented and data were analysed. Results: A total of 113 patients who had complete endoscopy were enrolled. The prevalence of H. pylori infections recorded was 27 (23.9%) patients. There were 17 (62%) male and 10 (37%) female infected with H. pylori (P = 0.33). All biopsied specimens were sent to pathology lab for examination. The most common endoscopic findings was erythematous antral gastritis (40.7%) followed by erosive gastritis 34 (30.1%), pangastritis 10 (8.8%), duodenal ulcer 13 (11.5%), gastric ulcer 9 (8%), erosive fundal gastritis 2 (1.8%), reflux esophagitis 10 (37%) (P < 0.04). Histology revealed that 23 (85.2%) patients had chronic active gastritis (CAG); (P < 0.001). Conclusions: Our study revealed that H. pylori infection is strongly associated with chronic active gastritis (CAG) and Reflux esophagitis in Nepalese adults.

Keywords: Chronic active gastritis, dyspepsia, Helicobacterpylori


How to cite this article:
Mandal AK, Kafle P, Puri P, Chaulagai B, Sidhu JS, Hassan M, Paudel MS, Kanth R, Gayam V. An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population. J Family Med Prim Care 2019;8:1227-31

How to cite this URL:
Mandal AK, Kafle P, Puri P, Chaulagai B, Sidhu JS, Hassan M, Paudel MS, Kanth R, Gayam V. An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population. J Family Med Prim Care [serial online] 2019 [cited 2019 Oct 20];8:1227-31. Available from: http://www.jfmpc.com/text.asp?2019/8/3/1227/254927




  Introduction Top


H. pylori, is a Gram-negative pathogen that chronically infects at least 50% of the world's population; its annual incidence is more in developing countries in comparison to developed countries.[1] In developing countries, more than 80% of the population is H. pylori positive.[2]

The strong association of H. pylori with dyspepsia has caused a drastic change in the patient management.[3]

Esophagogastroduodenoscopy (EGD) is usually performed due to persistent dyspeptic symptoms and/or presence of alarming symptoms for organic lesion. The vast majority of infections despite asymptomatic; have histological evidence of gastritis. The literature shows that H. pylori is associated with superficial chronic active gastritis, characterized by neutrophils in addition to lymphocytes and plasma cells.[4] Documented risk factors for H. pylori include low socioeconomic status, overcrowding, poor sanitation or hygiene, and living in a developing countries.[5]


  Materials and Methods Top


This was a cross sectional study carried out at National Academy of Medical Sciences (NAMS) from Oct 2014 to Jan 2015. The study was approved by Institutional Review Board (IRB) of NAMS. We included patients who were age 18 years and/or older who presented to Gastroenterology outpatient clinic at NAMS, Bir hospital with symptoms of dyspepsia. An informed written consent was taken from all participants. Demographic data was collected in a questionnaire prepared for the study.

We have excluded patients who did not give consent for study, on histamine-2 receptor blockers, sucralfate and non-steroidal anti-inflammatory drugs, who had severe co-morbid conditions including respiratory disorders, recent MI, shock, patients with upper gastrointestinal bleeding, history of partial gastric resection, and normal EGD finding.

An upper gastrointestinal endoscopic examination was performed with a FUJINON scope after an overnight fasting and stopping PPI for 4 weeks. EGD was performed by an expert endoscopist.

A biopsy was taken from antrum, body and fundus preserved in formalin and sent for histopathological analysis. Sections were stained with routine Haematoxylin and Eosin for detection of H. pylori and gastritis. Giemsa stain was also used for better yield of H.pylori infection. Slides were examined microscopically for H. pylori by the Pathologist. Presence of H. pylori was regarded as positive while absence was regarded as negative. A histopathological finding of chronic active gastritis was also noted.

All data were entered in Microsoft EXCEL and analyzed by SPSS 16 (Statistical Package for Social Sciences) software.

Continuous data were expressed as mean and standard deviation whereas categorical data were expressed as number (percentage). Continuous data were analyzed using t-test and categorical data were analyzed using Chi-square test.


  Results Top


Among the 113 participants who underwent EGD, there were 62 male and 51 female; mean age of the patients was 36.4 years with age ranging between 16 and 88 years. Seventeen patients were excluded from the study due to presence of normal findings on EGD. All patients underwent EGD and simultaneous biopsy for detection of presence or absence of H. pylori based on histopathological studies. The flow chart of the study population is shown in [Figure 1].
Figure 1: Showing flow chart of the study populations

Click here to view


Of 27 (23.9%) patients infected by H. pylori; 17 (63%) were male and 10 (37%) were female. The infection by H.pylori did not differ significantly between males and females (P = 0.33). The age and sex of the patient cohort are shown in [Table 1]. Most of the patients presented with the symptoms of burning abdominal sensation, additionally the symptoms were not statistically different among the H.pylori positive and H. pylori negative group as shown in [Table 2].
Table 1: Age and sex distribution of the study population

Click here to view
Table 2: Spectrum of Clinical manifestation of the study population

Click here to view


The most common endoscopic findings was erythematous antral gastritis (40.7%) followed by erosive gastritis 34 (30.1%), pangastritis 10 (8.8%), duodenal ulcer 13 (11.5%), gastric ulcer 9 (8%) and erosive fundal gastritis 2 (1.8%) were detected. The endoscopic findings such as gastritis, gastric ulcer, duodenal ulcer were not significantly associated with H. pylori. Ten (37%) reflux esophagitis patients were H. pylori infected [Table 3].
Table 3: Esophagogastroduodenoscopy (EGD) findings of the patients

Click here to view


A histopathological finding of chronic active gastritis (CAG) was observed in H. pylori infection. Patients who had H. pylori had significantly higher CAG (85.2%) as compared to H. pylori negative subjects (P < 0.001). The histopathological findings of the study patients undergoing EGD are shown in [Table 4].
Table 4: Histopathological examination (HPE) findings

Click here to view



  Discussion Top


In our study, we documented the H. pylori infection of 23.9% which is in accordance with the report of 29.5% and 29.4% from the studies done by Rai et al. and Shrestha et al. respectively from Nepal.[6] The other studies from Nepal, however revealed the prevalence ranging between 16.3 and 70.5%.[7],[8],[9],[10],[11],[12] H. pylori is a major pathogen of the gastrointestinal tract and it has been linked to a wide spectrum of gastric disorders, including gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue lymphoma.[13],[14] However, the infection remains latent in the majority of infected patients, and only few of them with H. pylori infection develop the disease and its complications.[15]

Makaju et al. in a dyspeptic patient observed a prevalence of 33.9%, which is slightly higher as compared to our study, however their study was a decade older and current prevalence might be decreased due to excellent diagnostic modality resulting in earlier treatment as well as empirical therapy in our populations.[11] A study from Turkey by Ceylan et al. also observed a very similar prevalence of 23.6% similar to present study.[16]

These data indicates that currently the prevalence of H. pylori infections in developing nations may not be very high as was reflected from some of the older studies. A significantly higher rate of infection in an urban population (78.8%) than in a rural population (69.2%), have been reported by Kawasaki et al. from Nepal.[17],[18]

The prevalence of H. pylori infection varies between different countries, as well as different geographic area within the same country. It had shown that age and socioeconomic status of the patients also plays a significant role in infection.[19]

Our study is also consistent with Shrestha et al., Fraser et al. and Begue et al. findings without any difference in age and gender of H. pylori infection.[6],[20],[21]

A significant proportion of patients (37%) presenting with dyspepsia had reflux esophagitis in our study which is higher than Song et al. study (18.8%) from Korea [22] The higher prevalence in our study could be attributed to majority of patients with gastritis linked to antral parts of the stomach resulting in excess of acid secretion. However, we did not stratify the reflux esophagitis as per Los Angeles classification in our study, but a study from our same hospital (NAMS) by Kasyap et al., reported grades of esophagitis as follows: grade A 31.8%, grade B 39.4%, grade C 33.8% and grade D 4.9%.[23]

In our study, CAG was significantly associated with the presence of H. pylori infection. Our finding of histo-pathological association with H. pylori infections is also consistent with two other studies from Nepal by Dhakhwa et al. and Thapa et al., as well as very similar results by Schultz et al., who showed 87% cases had chronic active gastritis observed in H. pylori infected person.[6],[8],[24]

As H. pylori infection is very common;[1],[2] especially in the developing nations; patients with symptoms of dyspepsia tend to visit the family physicians or primary care doctors and are subsequently referred to the specialist in case of H. pylori complications such as hematemesis, gastric cancer etc., Hence, the knowledge and awareness of this infection is equally important in general practice. Also we did not use the special stains for H. pylori detection keeping in mind of its limitations in the resource limited settings like ours. Unfortunately, poor patients cannot afford to pay for the multiple H. pylori tests such as stool for antigen test or urea breath test in order to confirm the diagnosis. In this situation, the histological evidence of CAG alone based on hematoxylin and eosin (H and E) and Giemsa stain may be used to treat H. pylori infections regardless of H. pylori seen histologically.[8],[24] This finding is also supported by our study and CAG may be used as a surrogate marker of H pylori infections.

Due to the use of over the counter antibiotics; the resistance of H pylori has been increasing for Clarithromycin and Metronidazole. So, the updated guidelines for the treatment of this infection are pivotal in reducing the emerging marcolide resistance. The American college of Gastroenterology (ACG) guideline and the Toronto Consensus (2016) advocate for a longer duration of treatment (14 days for almost all regimens).[25],[26] Either the Bismuth based quadruple therapy or the use of sequential treatment as a first-line therapy has been endorsed by these guidelines.

Patients should be asked about their previous exposure of antibiotic and this information should be bear in mind for the decision-making process while choosing a treatment regimen for H. pylori.


  Conclusions Top


Reflux esophagitis and CAG are commonly associated with H. pylori infections and the observations of CAG alone in a patient undergoing EGD for dyspepsia may be treated with anti- H. pylori therapy without further evidence of H. pylori infection, especially in the resource limited settings.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med 1990;322:359-63.  Back to cited text no. 1
    
2.
Pérez-Pérez GI, Sack RB, Reid R, Santosham M, Croll J, Blaser MJ. Transient and persistent Helicobacter pylori colonization in Native American children. J Clin Microbiol 2003;41:2401-7.  Back to cited text no. 2
    
3.
Jemilohun A, Otegbayo J, Ola S, Oluwasola A, Akere A. Diagnostic accuracy of rapid urease test for the diagnosis of Helicobacter pylori gastic biopsies in Nigerian with dyspepsia. Afr J Clin Exp Microbiol 2011;12:62-6.  Back to cited text no. 3
    
4.
Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;321:1273-5.  Back to cited text no. 4
    
5.
Brown LM. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 2000;22:283-97.  Back to cited text no. 5
    
6.
Begue RE, Gonzales JL, Correa-Gracian H, Tang S. Dietary risk factors associated with the transmission of Helicobacter pylori in Lima, Peru. Am J Trop Med Hyg 1998;59:637-40.  Back to cited text no. 6
    
7.
Thapa R, Lakhey M, Yadav PK, Kandel P, Aryal C, Subba K. Histopathological study of endoscopic biopsies. J Nepal Med Assoc 2013;52:354-6.  Back to cited text no. 7
    
8.
Shrestha S, Paudel P, Pradhan G, Shrestha L, Bhattachan C. Prevalence study of H. pylori infection in dyspeptic patients coming to Nepal Medical College Teaching Hospital, Jorpati, Kathmandu. Nepal Med Coll J 2012;14:229-33.  Back to cited text no. 8
    
9.
Dhakhwa R, Acharya I, Shrestha H, Joshi D, Lama S, Lakhey M. Histopathologic study of chronic antral gastritis. J Nepal Health Res Counc 2012;10:57-60.  Back to cited text no. 9
    
10.
Matsuhisa T, Miki M, Yamada N, Sharma S, Shrestha B. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: The age, gender and endoscopic diagnosis matched study. Kathmandu Univ Med J (KUMJ) 2007;5:295-301.  Back to cited text no. 10
    
11.
Makaju R, Tamang M, Sharma Y, Sharma N, Koju R, Ashraf M. Prevalence of Helicobacter pylori in Dhulikhel hospital, Kathmandu university teaching hospital: A retrospective histopathologic study. Kathmandu Univ Med J (KUMJ) 2005;3:355-9.  Back to cited text no. 11
    
12.
Shrestha R, Koirala K, Raj KS, Batajoo KH. Helicobacter pylori infection among patients with upper gastrointestinal symptoms: Prevalence and relation to endoscopy diagnosis and histopathology. J Family Med Prim Care 2014;3:154-8.  Back to cited text no. 12
[PUBMED]  [Full text]  
13.
Suerbaum S, Michetti P. Helicobacter pylori infection. N Eng J Med 2002;347:1175-86.  Back to cited text no. 13
    
14.
Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007;117:60-9.  Back to cited text no. 14
    
15.
Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90.  Back to cited text no. 15
    
16.
Ceylan A, Kırımi E, Tuncer O, Türkdoǧan K, Arıyuca S, Ceylan N. Prevalence of Helicobacter pylori in children and their family members in a district in Turkey. J Health Popul Nutr 2007;25:422-7.  Back to cited text no. 16
    
17.
Kawasaki M, Kawasaki T, Ogaki T, Itoh K, Kobayashi S, Yoshimizu Y, et al. Seroprevalence of Helicobacter pylori infection in Nepal: Low prevalence in an isolated rural village. Eur J Gastroenterol Hepatol 1998;10:47-50.  Back to cited text no. 17
    
18.
Hoang TTH, Bengtsson C, Phung DC, Sörberg M, Granström M. Seroprevalence of Helicobacter pylori infection in urban and rural Vietnam. Clin Diagn Lab Immunol 2005;12:81-5.  Back to cited text no. 18
    
19.
Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol 2010;25:479-86.  Back to cited text no. 19
    
20.
Fraser A, Scragg R, Metcalf P, McCullough S, Yeates N. Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Aust N Z J Med 1996;26:646-51.  Back to cited text no. 20
    
21.
Shrestha UK, Ghosh A, Alurkar VM, Kohli SC, Sapkota S. Prevalence of Helicobacter pylori infection, its correlation with gastroduodenal diseases and the incidence of gastric cancer in Nepal. J Adv Intern Med 2013;2:52-60.  Back to cited text no. 21
    
22.
Song HJ, Choi KD, Jung HY, Lee GH, Jo JY, Byeon JS, et al. Endoscopic reflux esophagitis in patients with upper abdominal pain-predominant dyspepsia. J Gastroenterol Hepatol 2007;22:2217-21.  Back to cited text no. 22
    
23.
Kasyap AK, Sah SK, Chaudhary S. Clinical spectrum and risk factors associated with asymptomatic erosive esophagitis as determined by Los Angeles classification: A cross-sectional study. PloS One 2018;13:e0192739.  Back to cited text no. 23
    
24.
Schultz M, Duarte I, Chianale J, Bravo R, Vergara M, Llanos J, et al. Frequency and Histopathologic features of chronic gastritis in 300 patients without endoscopic lesions. Rev Med Chil 1996;124:545-52.  Back to cited text no. 24
    
25.
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 2016;151:51-69. e14.  Back to cited text no. 25
    
26.
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: Treatment of Helicobacter pylori infection. Am J Gastroenterol 2017;112:212-39.  Back to cited text no. 26
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]


This article has been cited by
1 Review: Helicobacter pylori and non-malignant upper gastrointestinal diseases
Doron Boltin,Yaron Niv,Kerstin Schütte,Christian Schulz
Helicobacter. 2019; 24(S1)
[Pubmed] | [DOI]



 

Top
   
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
   Abstract
  Introduction
   Materials and Me...
  Results
  Discussion
  Conclusions
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed432    
    Printed4    
    Emailed0    
    PDF Downloaded61    
    Comments [Add]    
    Cited by others 1    

Recommend this journal